Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [1] Pharmacokinetics of Second-Line Antituberculosis Drugs in Children with Multidrug-Resistant Tuberculosis in India
    Kumar, Agibothu Kupparam Hemanth
    Kumar, Alok
    Kannan, Thiruvengadam
    Bhatia, Rakesh
    Agarwal, Dipti
    Kumar, Santosh
    Dayal, Rajeshwar
    Singh, Sheo Pratap
    Ramachandran, Geetha
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [2] A NOVEL CLINICAL PREDICTION RULE FOR MULTIDRUG-RESISTANT TUBERCULOSIS
    Estrada, Carlos
    Seas, Carlos
    Zamudio, Carlos
    Gotuzzo, Eduardo
    Martinez, Dalila
    Heudebert, Gustavo
    Henostroza, German
    Rodriguez, Martin
    Centor, Robert
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 211 - 211
  • [3] A NOVEL CLINICAL PREDICTION RULE FOR MULTIDRUG-RESISTANT TUBERCULOSIS
    Martinez, D. Y.
    Heudebert, G.
    Henostroza, G.
    Rodriguez, M.
    Zamudio, C.
    Centor, R. M.
    Gotuzzo, E.
    Estrada, C. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 486 - 486
  • [4] Novel treatments in multidrug-resistant tuberculosis
    Mondoni, Michele
    Saderi, Laura
    Sotgiu, Giovanni
    CURRENT OPINION IN PHARMACOLOGY, 2021, 59 : 103 - 115
  • [5] Number of drugs to treat multidrug-resistant tuberculosis
    Seung, KJ
    Joseph, K
    Hurtado, R
    Rich, M
    Shin, S
    Furin, J
    Leandre, FR
    Mukherjee, J
    Farmer, P
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (12) : 1336 - 1337
  • [6] Number of drugs to treat multidrug-resistant tuberculosis - Reply
    Caminero, JA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (12) : 1337 - 1337
  • [7] Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Tuberculosis
    Chahine, Elias B.
    Karaoui, Lamis R.
    Mansour, Hanine
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (01) : 107 - 115
  • [8] Multidrug-resistant tuberculosis
    Dheda, Keertan
    Mirzayev, Fuad
    Cirillo, Daniela Maria
    Udwadia, Zarir
    Dooley, Kelly E.
    Chang, Kwok-Chiu
    Omar, Shaheed Vally
    Reuter, Anja
    Perumal, Tahlia
    Horsburgh, C. Robert
    Murray, Megan
    Lange, Christoph
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)
  • [9] MULTIDRUG-RESISTANT TUBERCULOSIS
    GALAI, N
    GRAHAM, N
    CHAISSON, R
    NELSON, KE
    VLAHOV, D
    LEWIS, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16): : 1172 - 1173
  • [10] Multidrug-resistant tuberculosis
    Zager, Ellen M.
    McNerney, Ruth
    BMC INFECTIOUS DISEASES, 2008, 8 (1)
12345